Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biopsy
Study data from M.A. Vira and co-authors update knowledge of biopsy
June 3rd, 2008
According to a study from the United States, "To evaluate whether specific preoperative variables might better predict the concordance between biopsy and radical prostatectomy (RP) Gleason grade, and to assess the effect of the biopsy Gleason score (bGS) when controlling for the pathological GS (pGS) on clinical outcomes in patients undergoing RP. Between 1989 and 1998, 1088 men had RP at our institution, with a median follow-up of 56 months." "To evaluate the independent effect of bGS within categories of pGS, we stratified the sample by pGS (three categories; <= 6, 7, 8-10). Within each stratum we constructed Kaplan-Meier plots of recurrence-free survival by bGS...
Source: Cancer Weekly (2008-06-03)
|
